RIGL
USDRigel Pharmaceuticals Inc. Common Stock
$28.380-1.710 (-5.683%)
Reaalajas hind
Healthcare
Biotehnoloogia
Ameerika Ühendriigid
Hinnagraafik
Loading Chart...
Põhinäitajad
Turunäitajad
Avatud
$30.090
Kõrge
$30.795
Madal
$28.080
Maht
0.31M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
509.1M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.71M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Madal $13.91Praegune $28.380Kõrge $43.72
Seotud uudised
PR Newswire
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...
Vaata rohkem
CNBC
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.
Vaata rohkem
PR Newswire
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...
Vaata rohkem
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.